Commentary

Recently published articles about Commentary

JCP
Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step
JCP
The Goldilocks Problem: Balancing Internal Validity with Generalizability in Clinical Trials
JCP
MAOI Antidepressants: A History Being Rewritten
JCP
Gender-Affirming Perinatal Psychiatry for Transgender and Gender Diverse People
JCP
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
JCP
Why Getting Major Depression Right Matters—For Mothers, Babies, and All of Us
JCP
Prioritizing Mental Health to Optimize Perinatal, Fetal, and Neonatal Outcomes
JCP
Ketamine and Esketamine: Is There a Meaningful Clinical Difference?
JCP
The Emerging Science of Clinimetrics
JCP
Practitioners Providing Care for Persons with Severe Mental Disorders Should Routinely Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease
JCP
How Do We Get Ketamine Safety Right? Three Questions from a Clinical Service
JCP
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain